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Interaction of Epothilone Analogs with the Paclitaxel
Binding Site: Relationship between Binding Affinity,
Microtubule Stabilization, and Cytotoxicity
sic microtubule-disrupting drugs (colchicine, vinblas-
tine) block microtubule assembly by binding to the unas-
sembled tubulin dimers and inactivating them, paclitaxel
and docetaxel bind to microtubules, stabilizing them
and blocking their dynamics [2, 3]. Nevertheless, despite
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Ramiro de Maeztu 9 factors that hamper its applicability. First, its low aque-
ous solubility, and second, the development of pleiotro-28040 Madrid
Spain pic drug resistance mediated both by the overexpres-
sion of the P-glycoprotein [5, 6] and the presence of2 Winship Cancer Institute
Emory University School of Medicine mutations in -tubulin [7, 8].
The discovery in recent years of several natural sub-Atlanta, Georgia 30322
3 Department of Chemistry and stances with a paclitaxel-like mechanism of action
(epothilone, discodermolide, laulimalide, eleutherobin,The Skaggs Institute for Chemical Biology
The Scripps Research Institute peloruside, dictyostatin-1, taccalonolide, and jatro-
phane polyesters; [9–16]) opened new possibilities in10550 North Torrey Pines Road
La Jolla, California 92037 the field. Of these compounds, the first one recognized
as having a paclitaxel-like activity was an already knownDepartment of Chemistry and Biochemistry
University of California, San Diego natural compound called epothilone [9], a secondary
metabolite from the soil myxobacterium Sorangium cel-9500 Gilman Drive
La Jolla, California 92093 lulosum [17–19]. Epothilones are the most promising of
this group of new paclitaxel-like compounds because
they offer several advantages. First of all, while most of
the other compounds are isolated from marine organ-Summary
isms in limited amounts, epothilone B can be obtained
in kilogram amounts by fermentation [20]. Second, itThe interactions of epothilone analogs with the pacli-
has higher solubility in water than paclitaxel [19]. Third,taxel binding site of microtubules were studied. The
it is a worse substrate for the P-glycoprotein than pacli-influence of chemical modifications in the C15 side
taxel, and thus it is more effective than paclitaxel in cellschain and in C12 on binding affinity and microtubule
showing multidrug resistance [9, 21, 22]. Finally, it haselongation was characterized. Modifications favorable
a simpler molecular architecture, which has allowed thefor binding affinity are (1) a thiomethyl group at C21
total synthesis of the natural epothilones and many syn-of the thiazole side chain, (2) a methyl group at C12
thetic analogs [23–31].in S configuration, (3) a pyridine side chain with C15 in
The Nicolaou group initiated a program directed to-S configuration, and (4) a cyclopropyl moiety between
ward the design and synthesis of analogs [25–31], re-C12 and C13. The same modification in different li-
sulting in a large number of epothilone derivatives ingands has similar effect on affinity, allowing good
which the essential positions C12 and C13 and the sidestructure-affinity characterization. The correlation be-
chain in C15 have been modified in several ways (seetween binding, microtubule stabilization, and cytotox-
structures of several of these compounds in Figure 1).icity of the compounds has been determined, showing
But despite the effort made at characterizing the biologi-differential effects of the modifications. The binding
cal activity of the modifications, a limited effort has beenconstants correlate well with IC50 values, demonstra-
made on the chemical characterization of the microtu-ting that affinity measurements are a useful tool for
bule-epothilone interaction.drug design.
The study of the interaction between paclitaxel and its
derivatives with the binding site shared with epothilones
Introduction was greatly hampered by their mechanism of action
[32–33]. Since they preferentially bind to the assembled
The discovery in the early 1970s of paclitaxel in the bark form of tubulin inducing microtubule assembly, the as-
of the pacific yew (Taxus brevifolia) [1] turned later into sembly and binding are linked reactions [32]. Although
a revolution in the field of antimitotics. Paclitaxel and empty sites can be assembled in the absence of ligand
its derivatives, the best known of which is docetaxel at high tubulin concentrations, the high affinity of the
(a semisynthetic analog obtained from the precursor compounds makes it impossible to find conditions in
baccatin III, which is obtained in large amounts from which the reaction is not completely displaced toward
the leaves of the Mediterranean yew [Taxus baccata]), the end state, making it difficult to obtain an exact mea-
had at that time a unique mechanism of action among surement of the binding affinity of these compounds.
the other microtubule-perturbing drugs. While the clas- A procedure to stabilize assembled microtubules has
made it possible to obtain taxoid binding sites that can
be diluted to concentrations low enough to directly mea-*Correspondence: fer@akilonia.cib.csic.es
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Figure 1. Scheme of the Structures of Epothilone Analogs Employed in This Study, the Chemical Differences between Them, and the Effect
of These Modifications in the Free Energy of Binding to Their Site in Microtubules at 35C
sure the binding affinity of two fluorescent derivatives like mechanism. The ability of two natural epothilones
(epothilone A and epothilone B) to induce the assemblyof paclitaxel, Flutax-1 and Flutax-2 [34], and to develop a
competition method that has been employed to measure of GDP tubulin was tested. The inactive form of the
protein (10 M GDP tubulin in PEDTA 4 GDP buffer)the binding affinity of compounds that bind to the pacli-
taxel site, such as baccatin III [35], docetaxel and undergoes ligand-induced assembly in the presence of
a 2-ethoxyestradiol analog (3,17-diacetoxy-2ethoxy- stoichiometric amounts of the ligand as it does in the
6oxo-B-homo-estra-1,3,5(10)-triene) [36], epothilones A presence of paclitaxel. Electron microscopy controls
and B and several analogs [30], and paclitaxel [37], and were routinely performed on all assembled samples in
also to distinguish them from compounds with similar order to confirm that the polymers were microtubules.
effects, but which do not bind to the paclitaxel binding The stoichiometry of the binding was measured: 10
site, such as laulimalide [36]. M solutions of GDP or GTP tubulin in PEDTA 4 GDP
The purposes of this study were as follows: (1) to for GDP tubulin or PEDTA 4 GTP buffer for GTP tubulin
determine the structure-affinity relationship of a group were incubated with increasing concentrations of epo-
of chemically modified epothilones (Figure 1) and to thilone A and epothilone B. The amount of ligand in the
learn how to increase epothilone binding affinity, and microtubule pellet was found to be 1 mol per mol of
(2) to determine the correlations between affinity, cyto- assembled tubulin, independently of the nucleotide
toxicity, and microtubule stabilization in order to facili- bound (epothilone A, GDP tubulin 1.01  0.05, GTP
tate the design of compounds with a higher activity in tubulin 0.99  0.08; epothilone B, GDP tubulin 1.05 
killing tumoral cells. 0.07, GTP tubulin 1.02  0.04). (All experimental nota-
tions in this manuscript are standard errors of the mean.)
As for paclitaxel and docetaxel [32], in these conditions,Results and Discussion
assembly and binding of epothilone are linked; that is,
every tubulin heterodimer assembled into microtubulesMechanisms of Microtubule Stabilization
has a molecule of epothilone bound (Figures 2A and 2B).by Epothilones
Unless an excess of ligand is present in the assemblyThe biochemical mechanisms of epothilone-induced tu-
solution, all the ligand is bound to the assembled tubulin,bulin assembly were studied first in order to confirm that
the compounds stabilize microtubules with a paclitaxel- and in the supernatant ligand is practically undetectable.
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ing sites in the assembled microtubules are filled, this
result might suggest binding of the ligand to unassem-
bled tubulin (which will activate a second ligand-medi-
ated pathway; see Equation S2A in the Supplemental
Data).
The effect of Mg2 on the epothilone-induced assem-
bly was studied by adding growing concentrations of
Mg2 to 10 M solutions of GTP tubulin containing 12
M epothilone A or B in PEDTA GTP buffer. Epothilone-
induced GTP tubulin assembly is dependent on Mg2
(Figure 2C) as is the case for paclitaxel-induced GTP
tubulin assembly [38]; both drugs require free concen-
trations of Mg2 in the range of mM to induce assembly.
Tubulin with GDP bound to the E site has the same Mg2
requirement (data not shown).
The results above show that epothilones induce as-
sembly in a paclitaxel-like way, assembly and binding
being linked. This implies that in these experimental
conditions the intrinsic binding cannot be isolated,
which makes it extremely difficult to measure binding
constants. Binding affinity of epothilones for microtu-
bules seems to be high because free concentrations of
ligand can only be detected at overstoichiometric ratios
of ligand to tubulin. Experiments were run in which 5
M empty ligand sites assembled from GTP tubulin in
GAB 1 mM GTP were incubated with epothilone. Essen-
tially all the ligand was found bound to the microtubules,
indicating a binding affinity higher than micromolar.
Since at least micromolar concentrations of tubulin are
needed to assemble microtubules, in these experimen-
tal conditions the reaction is fully displaced toward the
bound state and binding constants cannot be measured.
Binding of Epothilone Analogs to Stabilized
Microtubules: Structure-Affinity Relationships
Figure 2. Biochemical Characterization of Epothilone-Induced As-
and Increment Thermodynamic Parameterssembly of Tubulin
of Group Modification(A and B) Linkage between epothilone binding and tubulin assembly.
Since it is not possible to measure the binding affinityGTP tubulin (10 M) in PEDTA7 GTP was incubated with growing
of epothilone to ligand-free glycerol-induced microtu-amounts of (A) epothilone A and (B) epothilone B. Tubulin concentra-
tions in pellet (solid circles) and supernatants (empty circles) and bules, it was necessary to use microtubules stabilized
epothilone concentrations in pellet (empty squares) were measured against dilution and cold by gentle crosslinking [34, 35].
as described in Experimental Procedures. Insets: Critical concentra- A test based in the displacement of a fluorescent taxoid
tions of epothilone-induced GTP tubulin polymerization in PEDTA
probe (Flutax-2) from its binding site in these stabilized4 GTP measured by centrifugation as described in Experimental
microtubules has been employed to measure bindingProcedures. Tubulin concentrations in pellet, solid circles; in super-
affinities relative to that of Flutax-2 (Figure 3) [30, 35, 36].natants, empty circles.
(C) Requirement of Mg2 for epothilone-induced tubulin assembly. The epothilone-microtubule binding was previously
GTP tubulin (10 M) in PEDTA GTP buffer containing 12 M epothi- characterized using the natural compounds epothilones
lone A (circles) or epothilone B (squares) was incubated with growing A and B. Epothilone B binds more strongly than epothi-
amounts of MgCl2. Tubulin concentrations in pellet (solid figures) lone A to its site in crosslinked microtubules (Ka 37Cand supernatants (empty figures) were measured by centrifugation.
in GAB 0.1 mM GTP; epothilone A, 2.93  0.44  107Note that the total [MgCl2] mM upper scale is only for the reader’s
M1; epothilone B, 60.8  10.1  107 M1); compatibleconvenience and it is neither linear nor logarithmic.
values (epothilone A, 5 2 107 M1; epothilone B, 50
20  107 M1) were obtained using direct sedimentation
measurements, which further validates the Flutax-2 dis-Since the critical concentration (tubulin concentration
in the supernatant) saturates with ligand concentration, placement method. When compared with the paclitaxel
group of drugs (Ka 37C paclitaxel 1.07  0.11  107the assembly process should follow the ligand-mediated
pathway (see Supplemental Data available with this arti- M1, docetaxel 3.09  0.22  107 M1 in GAB, 0.1 mM
GTP), epothilone A binds with similar affinity to thosecle online). A slight difference from the results obtained
with paclitaxel [38] is that the tubulin concentration in ligands, while epothilone B is 20 times more powerful.
The reaction is endothermic (HEpoA 	65 2 kJ mol1,the supernatant decreases at overstoichiometric con-
centrations of epothilone. Since at these epothilone con- HEpoB 	 70  7 kJ mol1) and enthalpy driven.
The effect of Mg2 ions, pH, and ionic strength incentrations (
1 M free epothilone) all epothilone bind-
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Figure 3. Competition between Flutax-2 and
Epothilones for the Paclitaxel Binding Site
Displacement of the fluorescent taxoid Flu-
tax-2 (50 nM) from microtubule binding sites
(50 nM) by taxoids and epothilone analogs at
35C. The points are data and the lines were
generated with the best fit value of the bind-
ing equilibrium constant of each competitor,
assuming a one to one binding to the same
site. Ligands are as follows: in (A), epothilone
A (compound 1), black; epothilone B (com-
pound 2), red; docetaxel, yellow; paclitaxel,
cyan. In (B), epothilone A, (compound 1),
black; cis-CP-py-EpoA (compound 4), red;
trans-CP-EpoA (compound 5), yellow; trans-
CP-py-EpoA (compound 7), cyan; trans-CP-
tmt-EpoA (compound 10), gray; cis-CP-EpoA
(compound 14), green; trans-CB-EpoA (com-
pound 15), blue; cis-(15R)-CP-EpoA (com-
pound 16), pink; cis-(15R )-CP-py-EpoA
(compound 17), violet; trans-(15R )-CP-py-
EpoA (compound 18), brown; cis-CP-tmt-
EpoB (compound 19), orange. The lines
shown with compounds 17 and 18 data corre-
spond to simulated equilibrium binding con-
stants of 6,000 and 12,000 M1, respectively
(accurate determinations were precluded by
the availability of more concentrated stock
solutions).
the binding were characterized as well and have been similarly for the incremental enthalpy and entropy
changes. These incremental binding thermodynamicshown to be weak in the range studied (1–9 mM Mg2,
0–1 M NaCl, 6–7 pH). Mg2 ions, although necessary for parameters are summarized in Table 2. Before starting
the detailed analysis, we should keep in mind that al-ligand-induced assembly, have very little influence on the
affinity of the drugs for their site, indicating that no addi- though it is possible to dissect the incremental changes
in Gibbs free energy into their enthalpy and entropytional Mg2 ion is incorporated with ligand binding [39].
The structure-affinity relationship of the side chain contributions, these individual contributions are difficult
to analyze because of the enthalpy-entropy compensa-and of the epoxy moiety of the epothilones has been
studied using a selected group of chemically modified tion effect (in aqueous solutions, enthalpy changes due
to the presence of new electrostatic interactions can beepothilones. Modifications have been made in positions
12, 15, and 21 of the epothilone molecules (Figure 1), transformed into entropy changes due to rearrangement
of the water molecules [40, 41], which may lead to uncer-which are important for activity [25]. These 20 com-
pounds are related by a series of single group modifica- tainty in the interpretation of incremental enthalpy and
entropy terms).tions, which are indicated by the colored arrows in Fig-
ure 1. The binding Gibbs free energy, enthalpy, and
entropy changes can be estimated by measuring the Modifications at C15 and the Side Chain
C15 Stereochemistrybinding affinities of the compounds to microtubules (Ta-
ble 1 and Figure 3). The measurement of the affinities The stereochemistry of this carbon is critical for epothi-
lone binding affinity; C15 has to be in an S configurationof a series of ligands for their site in a protein is a
classical way to study the specificity of a protein-ligand in order to have a high-affinity binding. Molecular mod-
els built from the X-ray structure of epothilone A mole-interaction, and it can be a good approximation of the
incremental binding energy provided by each group [40]. cule [42] show that, with C15 in the S configuration, the
side chain is roughly in the plane of the epothilone ring,The incremental binding free energy change associated
with the modification of ligand A into ligand B is defined while if the carbon is in the R configuration, the side
chain is perpendicular to this plane. Epimerization ofas follows: G0app(A→B) 	 G0app(B)  G0app(A), and
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Table 2. Incremental Thermodynamic Parameters of Binding of Epothilone Analogs to Microtubules
Single Group Modification Compounds G0app H0app S0app
(kJ mol1 at 308 K) (kJ mol1) (J mol1K1)
C15 S to R 4→17 27 ND ND
7→18 27 ND ND
14→ 16 17.8  0.3 26  4 25  11
C15 side chain thiazole→pyridine 5→7 2.9  0.2 7  4 35  14
6→8 2.1  0.3 15  9 54  28
14→4 0.2 0.4 3  4 10  12
16→17 9.4 ND ND
C21 methyl to thiomethyl 2→3 2.8  0.8 33  13 122  44
5→10 5.9  0.6 37  8 135  24
6→11 3.6  0.3 23  9 86  28
8→12 2.6  0.3 16  9 58  27
C21 methyl to hydroxymethyl 8→9 1.4  0.3 23  8 76  25
5-thiomethyl-pyridine to 12→13 4.1  0.5 13  6 30  20
6-thiomethyl-pyridine
C12 S to R 4→7 2.1  0.3 3  5 23  13
14→5 0.6  0.3 1  4 2  12
17→18 2 ND ND
19→11 9.0  0.6 ND ND
20→8 1.9  0.4 26  10 75  31
epoxide→cyclopropyl 1→14 4.7  0.4 8  3 38  11
3→19 5.4  0.8 ND ND
cyclopropyl→cyclobutyl 5→15 4.1  0.2 8  4 11  11
C12S H to methyl 1→2 8.1  0.6 5  7 8  25
4→20 1.8  0.5 8  8 36  25
C12R H to methyl 5→6 0.4  0.3 23  6 69  22
7→8 1.2  0.2 31  9 88  27
10→11 2.7  0.7 9  10 20  31
this chiral center from S to R results in low-affinity com- crease in binding affinity is due to the entropic term,
since the contribution of the enthalpy term is unfavor-pounds, G35C(4→17)27 kJ mol1,G35C(7→18)
27 kJ mol1, G35C(14→16) 	 17.8 kJ mol1 (each able. As discussed above, when C15 is of the R configu-
ration, the introduction of the larger side chain resultstransformation is named with the numbers of the original
and the resulting compound; see Figure 1), suggesting in a loss of affinity, G35C (16→17)  9.4 kJ mol1.
Change of the C21 Substituentthat the side chain in the new position is not able to bind
the site, with the subsequent loss of binding enthalpy Three different groups (methyl, hydroxymethyl, and thio-
methyl) have been employed as substituents of the side(H0app(14→16)	 26 kJ mol1). Moreover, the new posi-
tion of the side chain in the C15R compounds may inter- chain ring at position C21. The effect of the substituents
in the binding to the paclitaxel site depends on the sidefere with the binding of the rest of the molecule. The
reason for this might be purely steric, since the larger chain ring to which they are attached.
When the side chain ring is a thiazole, the changethe side chain, the larger the loss in binding affinity
(compound 16 with a thiazole group retains larger affinity made was methyl to thiomethyl. The change is favorable
in the three examples, independently from C12 configu-than compounds 17 and 18 with pyridine side chains).
It has to be pointed out that a similar effect is observed rations: G35C(2→3) 	2.8 kJ mol1, G35C(5→10) 	
5.9 kJmol1, G35C(6→11)	 3.6 kJ mol1. In theif the stereochemistry of C13 is changed from S to R
as in C13R-cyclopropyl-epothilones, which have been three cases, the thermodynamic analysis of the modifi-
cation shows that the modification is highly unfavorableobtained as an unexpected result in the synthetic pro-
cess of cis-CP-EpoA (compound 14) [25, 28]. Those in the enthalpy term, but it is more strongly favorable
in the entropy term, turning the binding reaction fromligands are inactive, probably because this modification
will place the C15 side chain in a similar position (under enthalpy driven into entropy driven.
Compounds having a thiomethyl-thiazole side chainthe plane of the ring) to that occupied by the side chain
in the C15R compounds 16, 17, and 18. include the most powerful epothilone analogs studied,
cis-CP-tmt-EpoB (G35C (19 ) 	 60.8 kJ mol1), tmt-Change of the C15 Side Chain Ring
Two different groups have been employed as C15 side EpoB (G35C (3) 	 55.4 kJ mol1), and trans-CP-tmt-
EpoA (G35C (10) 	 54.5 kJ mol1). The second one ischain ring, thiazole and pyridine. Out of the four exam-
ples studied, the modification was favorable in two just the result of this single modification in the natural
epothilone EpoB. In the case of compound 19, the bind-cases, neutral in one, and unfavorable in one case, de-
pending on the stereochemistry of C12 and C15. With ing affinity of the compound (1010 M1) is very much
higher than those of the fluorescent probe (107 M1),C12 and C15 in their natural S configuration, the modifi-
cation was practically neutral, G35C(14→4)	0.2 kJ precluding reliable dissection of the incremental changes
in Gibbs free energy into their enthalpy and entropymol1. The modification thiazole for pyridine was favor-
able with C12 in the R configuration: G35C(5→7) 	 contributions.
When the side chain is pyridine (with C12 being of the2.9 kJ mol1, G35C(6→8) 	 2.1 kJ mol1. The in-
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R configuration), the same modification (thiomethyl for modification results in a loss of binding affinity:
G35C(5→6) 	 0.4 kJ mol1, G35C(7→8) 	 1.2 kJmethyl) results in a loss of binding affinity:G35C(8→12)	
2.6 kJ mol. A possible explanation is that the change mol1, G35C(10→11) 	 2.7 kJ mol1. The effect of
these modifications on the thermodynamic parametersfrom thiazole to pyridine may have placed the methyl
group in a better position for interaction, and the intro- of binding is an increase in the enthalpy of binding,
which is not compensated by the entropic benefit; theduction of the sulfur spacer between the ring and the
methyl, which has a favorable effect in the case of the net result being unfavorable for affinity.
thiazole side chain (it may place the methyl in a similar
position to the change from thiazole to pyridine), has a
Overview of Epothilone Structure-unfavorable effect in this case because it may displace
Activity Relationshipsthe methyl group from its ideal position. The change
Apart from the natural modification, the methyl groupfrom methyl for hydroxymethyl in the pyridine group has
in C12S which renders EpoB from EpoA, the most suc-a slightly unfavorable effect: G35C(8→9) 	 1.4 kJ
cessful modifications for affinity are the introduction ofmol1. Both modifications are favorable from the enthal-
the thiomethyl group in C21 as thiazole substituent andpic point of view but unfavorable in the entropic term.
the exchange of the epoxide moiety for a cyclopropyl.The change of the position of the thiomethyl group from
Surprisingly, the result of the introduction of the thio-position C5 to position C6 of the pyridine ring is unfavor-
methyl group is a complete change of the thermody-able, G35C(12→13) 	 4.1 kJ mol1; in this case, an
namic parameters of the binding, turning an enthalpy-increment in enthalpy, Happ(12→13) 	 13 kJ mol1, is
driven reaction (the binding of compounds 1, 2, 5, 14,not compensated with the increment in entropy,
15, and 16, i.e., the compounds with a methyl-thiazoleSapp(12→13) 	 30 kJ mol1K1.
side chain except compound 6 proceed with a unfavor-
able entropy contribution to the free energy of binding)
into an entropy-driven reaction (the binding of com-C12 Modifications
C12 Stereochemistry pounds 3, 10, and 11, i.e., all compounds with a thio-
methyl-thiazole side chain proceed with a large favor-The result of the change of the stereochemistry of C12
from S to R depends on the side chain bound to the able entropic contribution to the free energy of binding).
Changes in the hydrophobic surface of the ligand atC15 and on the substituents at C12. For epothilone A
analogs, (1) if the side chain is thiazole, the observed selected points may possibly improve binding by en-
hancing certain hydrophobic interactions. In fact, thechange in affinity is almost neutral, G35C(14→5) 	
0.6 kJ mol1; (2) if the side chain is pyridine, the change paclitaxel binding site has been described as a hy-
drophobic pocket [43]. Another example of this is thehas a favorable effect, G35C(4→7) 	 2.1 kJ mol1.
This modification has no large effects on the enthalpy substitution of thiazole for pyridine (which is favorable
or neutral as long as C15 is in S configuration [com-and entropy of binding. The same transformation ap-
plied to a low-affinity ligand cis-(15R )-CP-py-EpoA re- pounds 4, 7, 8]). The increase in binding affinity results
from a similar effect to that produced by the introductionsults in a similar change in bindingaffinityG35C(17→18)
2 kJ mol1. For epothilone B analogs, the modification of the thiomethyl group as thiazole substituent; that is,
an increase of the entropic contribution to the free en-is unfavorable with side chain thiazole, G35C(19→11) 	
9.0 kJ mol1, and side chain pyridine, G35C(20→8)	 ergy of binding, which compensates for a moderate de-
crease in the enthalpic component. It is tempting to1.9 kJ mol1. In this case, the enthalpic contribution
is so highly unfavorable that the favorable entropic con- suggest in explanation of these results that the increase
in size of the group to which the methyl group is attachedtribution is not enough to compensate for it.
Chemical Modifications of the Epoxy Group places the methyl substituent in a better position for a
hydrophobic interaction, leading to an entropy-drivenAnother modification examined is the transformation of
the epoxy group of epothilone A into a cycloalkyl group. reaction. Any further modification of the methyl substitu-
ent of the pyridine ring results in loss of affinity due toA cyclopropyl group increases the binding affinity:
G35C(1→14) 	 4.7 kJ mol1, G35C(3→19) 	 5.4 a large decrease of the entropy of binding.
The change of the stereochemistry of C12 from S tokJ mol1.
A further modification was the increase in size of the R has as well a weakly favorable entropic effect, so it
may as well involve a modification of a hydrophobiccycloalkyl group by substituting the cyclopropyl group
by a cyclobutyl, G35C(5→15)	 4.1 kJ mol1. The interaction. The effect of the introduction of a methyl
group at position C12 has opposite effects, dependingdecrease of binding affinity is due to an increase in the
enthalpy of binding, which is not compensated by the on the stereochemistry. In the C12S configuration (the
natural one), it has a favorable effect: G35C(1→2) 	entropic benefit of the more hydrophobic group.
Introduction of a Methyl Group in C12 8.1 kJ mol1, G35C(4→20) 	 1.8 kJ mol1. If C12
is in the R configuration, the effect is favorable in theThis modification occurs in the natural epothilone B,
and it strongly favors binding in the natural epothilone entropic term and unfavorable in the enthalpy term; in
this case, the gain in the entropic term can not compen-with C12 in S configuration (G35C(1→2) 	 8.1 kJ
mol1) with moderate benefits in both enthalpic and en- sate the loss, resulting in a decrease of binding affinity.
This is also observed in the case of the favorable modifi-tropic terms of the free energy change. The modification
is also favorable (although not so strongly) in the other cation G35C(4→20) 	 1.8 kJ mol1, with C12 in the
S configuration and a cyclopropyl instead of epoxide,example studied (G35C(4→20) 	 1.8 kJ mol1). The
rest of the examples available in this study have this which is far less favorable than G35C(1→2) 	 8.1 kJ
mol1, favorable for both terms of the free energy. Thiscarbon in the R configuration, and in all these cases the
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Table 3. Comparison of Ligand Binding Affinities at 37C, the Critical Concentration Values of Ligand-Induced Microtubule Assembly,
and the Cytotoxicity of Epothilones and Paclitaxel against 1A9 Human Ovarian Carcinoma Cells
Compound Cr M Kel2 *1e5 (M1) 1/Kbin1 (nM) IC50 (nM)a
Paclitaxel 4.24  0.49 2.35  0.24 93  9b 1.30  0.22
Docetaxel 1.52  0.25 6.58  0.93 32  3 0.45  0.25
Epothilone A [1] 5.11  0.15 2.93  0.44 34  4 3.10  0.72
Epothilone B [2] 1.17  0.12 8.55  0.80 1.6  0.1 0.30  0.05
tmt-EpoB [3] 0.72  0.089 13.89  1.53 0.51  0.07b 0.17  0.08
cis-CP-py-EpoA [4] 1.53  0.10 6.53  0.40 5.2  0.8 1.40  0.45
trans-CP-EpoA [5] 1.27  0.21 7.87  1.11 6.5  0.1 2.70  0.10
trans-CP-EpoB [6] 2.19  0.30 4.57  0.55 8.8  0.4b 15.00  0.00
trans-CP-py-EpoA(7) 1.53  0.10 6.53  0.40 2.1  0.4 0.62  0.17
trans-CP-py-EpoB(8) 1.19  0.21 8.40  1.26 3.5  0.3b 1.70  0.76
trans-CP-pyOH-EpoB(9) 1.70  0.18 5.88  1.26 6.0  0.6 1.70  1.12
trans-CP-tmt-EpoA(10) 1.44  0.12 6.94  0.53 0.71  0.14b 1.20  0.67
trans-CP-tmt-EpoB(11) 1.36  0.21 7.35  0.98 1.8  0.2 3.50  1.64
trans-CP-5tmpy-EpoB(12) 2.54  0.10 3.94  0.15 9.6  1.3b 14.20  5.73
trans-CP-6tmpy-EpoB(13) 9.65  2.46 1.04  0.21 42  7b 114.00  0.00
cis-CP-EpoA(14) 0.93  0.17 10.75  1.66 5.7  0.4 1.60  0.12
trans-CB-EpoA(15) 2.97  0.12 3.36  0.13 32  3 25.5  1.5
cis-(15R )-CP-EpoA(16) 
50 0.2 5300 225
cis-(15R )-CP-py-EpoA(17) 
50 0.2 170,000 
300 (inactive)
trans-(15R )-CP-py-EpoA [18] 
50 0.2 83,000 
300 (inactive)
cis-CP-tmt-EpoB [19] 0.38  0.07 26.3  4.1 0.063  0.006 0.1  0.0
cis-CP-py-EpoB [20] 0.71  0.03 14.1  0.6 1.9  0.1 0.3  0.1
a Data taken from [29–31].
b These data differ from those previously published [30] since they have been measured again with higher precision.
suggests that the effect should be due to the loss of 0.31 0.07M, while the weakest inductor is compound
13, Cr 10.75  1.66 M, which is the epothilone withthe negative charge provided by the oxygen, whose
the lowest affinity (except for the inactive compoundsinteractions with the tubulin may be favored by the pres-
16, 17, and 18). Epothilone B is a more powerful assem-ence of the methyl at C12.
bly inducer than epothilone A. The critical concentrationThe effect of the modifications is accumulative, re-
of epothilone B-induced assembly is four times lowersulting in the EpoB analog with the C12-C13 cis cyclo-
(Cr EpoB, 1.17  0.12 M; Cr EpoA, 5.11  0.15 M).propyl moiety, and the thiomethyl-thiazole as side chain
The comparison between the binding affinities of the(cis-CP-tmt-EpoB) having the largest affinity of all
ligands to their site Kbin1 and the equilibrium constantthe compounds studied, G35C(cis-CP-tmt-EpoB) 	
for the growth reaction Kel2 (Figure 4A) shows that they60.8  0.5 kJ mol1.
correlate (r2 	 0.62), although the changes in the appar-
ent free energy of elongation are much smaller than
Comparison between Epothilone Binding those in the apparent free energy of binding (slope 	
Affinities and Their Microtubule 0.39). The analogs that stabilize microtubules better than
Stabilization Activity corresponds to their binding activity (i.e., those signifi-
In order to better understand the structure/activity rela- cantly over the best regression line) are compounds
tionship of this group of epothilone analogs, it should 5 and 14 (the two cis-trans isomers of CP-EpoA) and
be taken into account that the effect of the ligands on compounds 8 and 20 (the two cis-trans isomers of CP-
the system is microtubule stabilization. Thus, it would py-EpoB). On the other hand, compounds 10 and 13,
be interesting to quantitatively compare microtubule as- both containing the thiomethyl substituent, are signifi-
sembly induced by these ligands. If, as discussed above, cantly under the best regression line, being the ones
the epothilone-induced assembly mechanism follows with the worst Kel/Kbin ratio. It should be noted that there
the ligand-mediated pathway, the apparent critical con- are also two trends in the data that may point to the
centration (Cr) of ligand-induced assembly measured influence of the substitutions in the microtubule stabili-
in the presence of an excess of ligand is in a good zation activity of the ligands. (1) In addition to com-
approximation of the critical concentration of the micro- pounds 5 and 14, epothilone A and two other epothilone
tubules bound to epothilone (see Supplemental Data A analogs (compounds 4 and 15) are slightly over the
available with this article online) (i.e., 1/Cr 	 Kapp	 Kel2). best regression line, which is only the case for epothi-
Kel2 can be then directly compared to the binding con- lone B analogs containing pyridine in the side chain
stants of the ligand to their empty site in microtubules, (compounds 8, 9, and 20). (2) Compounds that contain
Kbin1. the thiomethyl substituent tend to have lower assembly
The critical concentrations of microtubule assembly induction power than expected, i.e., compounds 10, 11,
induced by paclitaxel, docetaxel, and the epothilone 12, 13, and 19.
analogs at 37C were measured (Table 3). Out of the Although assembly induction and binding affinity are
compounds studied, the strongest assembly inductor not necessarily related, since they are different reactions
with different intrinsic equilibrium binding constants,is compound 19, the one with the highest affinity, Cr
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expected from its binding affinity, two groups of com-
pounds whose separate best regression lines differ by at
least 2 intervals (data not shown) may be distinguished.
The first one (compounds 2, 3, 4, 5, 7, 8, 9, 14, 15,
and 20) has a higher cytotoxicity/affinity ratio than the
second group of six compounds (compounds 6, 10, 11,
12, 13, and 19), which include five of the six compounds
containing the thiomethyl group. The first group of com-
pounds have an IC50 which is 2 to 3 times lower than their
dissociation constants from stabilized microtubules (a
difference that might be related to a similar difference
between the binding affinities of stabilized microtubules
and MAPs (microtubule associated proteins) containing
microtubules for the fluorescent probe ligand employed
[34, 37]. The second group of compounds have IC50s
that are half of their Kd, so this group of compounds is
around 5 times less effective (relative to their binding
affinity) in killing tumor cells than the other group. It
should be noted that all the compounds of this group
have a highly favorable entropic contribution to the bind-
ing affinity.
The two natural compounds, epothilone A and epothi-
lone B, which are the ones with the lowest enthalpy
of binding (Happ 	 65  2 and 70  7 kJ mol1,
respectively), are the ligands with the highest ratio be-
tween IC50 and binding constant (IC50/Kbin1 	 11 and 5.3,
respectively). This suggests that modifications that im-
prove the favorable enthalpic component of binding
would render analogs with increased cytotoxicity.
In summary, it can be said that the measurement of
binding affinities is a useful tool for designing com-
pounds with a larger cytotoxicity, since (1) favorable and
unfavorable contributions to the binding of the different
groups are accumulative, so new epothilone analogs
Figure 4. Comparison of Binding Affinity, Microtubule Stabilization,
with higher affinity can be designed on the basis of theand Cytotoxicity of the Epothilone Analogs
results. (2) It is possible to dissect the effect of the(A) Dependence of the elongation constant of ligand-induced as-
modifications on the entropic and enthalpy terms ofsembly Kel2 on the binding constant to the paclitaxel site of microtu-
the free energy of binding. Modifications that increasebules Kbin1. The data of paclitaxel and docetaxel are not employed
for the regression. binding but have a unfavorable contribution on the en-
(B) Dependence of the IC50 of ligands against 1A9 human ovarian thalpic term seem to be less effective in increasing cyto-
carcinoma cells on the binding constant to paclitaxel binding site toxicity. (3) With the assay employed, it is possible to
of microtubules Kbin1. The data of paclitaxel, docetaxel, and epothi- rapidly rank the effect in the binding affinity of singlelone A are not employed for the regression. Solid lines are the best
modifications on epothilones.linear regressions to the experimental data; dashed lines are the
Although there is a correlation between Kel2 and IC5095% confidence intervals of the regressions.
(r 	 0.68) (Table 3), this is a trivial consequence of the
correlation between Kbin and Kel previously discussed.
Kbin1 and Kel2 (see Supplemental Data), the experimental There are several reasons to choose binding affinities
results indicate that they are somehow linked. However, as a better design tool than microtubule stabilization.
it should be noted that the chemical features that are First, at the IC50 concentrations, the free concentration
more effective in increasing binding affinity are not nec- of ligand in the cells should be of the order of nanomolar
essarily the same ones that improve the assembly induc- (not to be confused with the total concentration of ligand
tion capacity. in the cells, which is much higher [44] since the ligands
accumulate in the cells due to binding to the cellular
Correlation between Binding Affinities microtubules). These concentrations are too low to in-
and Cytotoxicity duce microtubule stabilization in vitro. With the known
Figure 4B shows the IC50 of the compounds in 1A9 cells binding and elongation equilibrium constants of the as-
(a human ovarian carcinoma cell line). The plot of log sembly process, it can be shown that the apparent mi-
IC50 versus log Kbin1 shows that both values correlate crotubule critical concentration should not be affected
well (r2 0.76, slope 1.22), suggesting that binding affinity at such low ligand-free concentrations (see Figure S1
is an important parameter involved in cytotoxicity. Cyto- in the Supplemental Data). It implies that the effect of
toxicity and affinity data are listed in Table 3. the ligand at IC50 concentrations should not be noticed
Apart from epothilone A, which is clearly over the best in microtubule stabilization but in the microtubule dy-
namics. Second, binding affinities are within the sameregression line, having a much better cytotoxicity than
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epothilone A, 249 12500 M1 cm1; epothilone B, 249, 14100 M1order of magnitude of the IC50 of the ligand, and changes
cm1 [19]). Paclitaxel (Taxol) was provided by the late M. Suffnessin binding affinity are reflected in relatively similar
from the National Cancer Institute (Bethesda, MD). Docetaxel (Taxo-changes in IC50, whereas critical concentrations are tere) was kindly provided by Rhoˆne Poulenc Rorer, Aventis (Schiltig-
three orders of magnitude higher than IC50, and large heim, France). Flutax-2 (7-O-[N–(4-2,7-Difluoro-Fluoresceincarbonil)-
differences in cytotoxicity are only reflected in small L-alanyl]-paclitaxel) was provided by Prof. Francisco Amat-Guerri; it
was dissolved in DMSO and its concentration was measured spectro-changes of the critical concentration (Table 3). And third,
photometrically (496 	 49100 cm1 M1 in 50 mM sodium phosphate,from the practical point of view the determination of
0.5% SDS, pH 7.0 [34]).critical concentrations requires biochemical manipula-
Buffers employed were as follows: GAB, glycerol assembly buffer,tions of a labile protein, while determination of the bind-
3.4 M glycerol, 10 mM sodium phosphate, 1 mM EGTA, 6 mM MgCl2
ing constants of several ligands can be made in a 96- (pH 6.5); PEDTA GDP, 10 mM sodium phosphate, 1mM EDTA, 1 mM
well plate using stabilized binding site preparations. GDP, (pH 6.7); PEDTA GTP, PEDTA GDP plus 1 mM GTP; PEDTA
4 GDP, PEDTA GDP with 4 mM MgCl2; PEDTA 4 GTP, PEDTA GTP
with 4 mM MgCl2; PEDTA 7 GDP, PEDTA GDP with 7 mM MgCl2;Significance
PEDTA 7 GTP, PEDTA GTP with 7 mM MgCl2.
Epothilones A and B induce microtubule assembly in
Preparation of Stabilized Microtubules
a paclitaxel-like way with a mechanism thermodynam- Stabilized crosslinked microtubules were prepared as described
ically equivalent to a ligand-mediated protein associ- [37]. To determine the exact concentration of sites in the microtu-
bules, 5 M Flutax-2 was added to a solution containing 2 M totalation.
tubulin concentration (as determined spectrophotometrically) inThe influence of chemical modifications in the C15
GAB, 0.1 mM GTP, in the presence or absence of 100 M docetaxel.side chain and at C12 of epothilone on binding affinity
The samples were centrifuged at 50,000 rpm for 20 min in a TL100and microtubule stabilization were characterized,
rotor employing a Beckman Optima TLX ultracentrifuge. Superna-
showing that the incremental binding free energy tants were taken and an aliquot of them was diluted 1:5 in 10 mM
changes of single modifications provide a good esti- phosphate, 1% SDS buffer (pH 7.0). The pellets were resuspended
in the same buffer and diluted 1:5. The concentrations of Flutax-2mation of the binding energy provided by each group.
in pellets and supernatants were measured fluorometrically usingModifications increasing binding affinity are as fol-
exc 495, ems 520 in Shimadzu RF-540 fluorimeter, employing spec-lows: (1) a thiomethyl group at C21 of the thiazole side
trophotometrically calibrated Flutax-2 standards. The amount ofchain, (2) a methyl group at C12 in the S configuration,
Flutax-2 pelleted in the presence of 100 M docetaxel had to be
(3) a pyridine side chain with C15 in the S configuration, substracted from the amount of Flutax-2 pelleted in absence of
and (4) a cyclopropyl moiety between C12 and C13. docetaxel. The resulting amount is the concentration of reversibly
bound Flutax-2 in saturation conditions, i.e., the concentration ofModifications 1 and 3 are unfavorable in the enthalpy
paclitaxel binding sites in the sample, which can be extrapolatedterm of the free energy and are very favorable in the
to the stock. Between 95% and 100% of the assembled tubulinentropy term, suggesting that they place the methyl
dimers were found to bind taxoid.substituent in a better position for a hydrophobic inter-
action. The ligand having all these favorable modifica-
Equilibrium Binding Constants of the Ligands
tions, cis-CP-tmt-EpoB, has the highest affinity (Ka to Microtubules
2.1  0.4  1010 M1 at 35C). The equilibrium binding constants of the different ligands to the
paclitaxel binding site of assembled microtubules were measuredThis study has provided useful information about
by the displacement of a fluorescent taxoid probe (Flutax-2) fromthe influence of single group modifications on three
its binding site. The displacement isotherm of each ligand was mea-activities: binding affinity, microtubule stabilization,
sured at least four times in two different plates with a fluorescenceand cytotoxicity. There are differential effects of the
polarization microplate reader, as described [35]. Crosslinked stabi-
modifications, as follows: (1) epothilone A analogs are lized microtubules that had been stored under liquid nitrogen were
more effective microtubule stabilizers than epothilone employed.
A mixture of 50 nM paclitaxel binding sites and 50 nM Flutax-2B analogs, (2) a thiomethyl group at position C21 of
in the desired buffer was sampled in a 96-well plate. Increasingthe thiazole side chain is more effective in increasing
concentrations of the competitor ligands were added to the wells.binding affinity than in increasing microtubule stabili-
After mixing the samples for 10 min by shaking at 250 rpm, theirzation, and (3) compounds with a favorable entropic
anisotropies were measured after 20 min incubation at the desired
contribution to binding are less effective in killing tu- temperatures using a POLARSTAR BMG plate reader in the polariza-
moral cells than those with a favorable enthalpic con- tion mode, employing the 480-P excitation filter and the 520-P emis-
sion filters. A sample containing 50 nM paclitaxel binding sites wastribution. Nevertheless, the influence of the modifica-
employed as blank, and a 50 nM solution of Flutax-2 in GAB, 0.1tions on the three activities correlate well, so it can
mM GTP was employed as anisotropy standard (polarization p 	be concluded that the determination of binding affinity
0.07). Measurements of the anisotropy of Flutax-2 completely dis-of epothilone analogs is a useful parameter to be max-
placed (in the presence of a large excess of docetaxel) and, in
imized in order to have compounds with higher ac- absence of the competitor ligand, are required for data processing.
tivity. The binding constants of the reference ligand Flutax-2 were mea-
sured by centrifugation and fluorescence anisotropy at each tem-
perature and buffer condition (Table 2; [34] and this work).Experimental Procedures
The binding of Flutax-2 (reference ligand) in the presence of the
competitor ligand (x 	 |Flutax-2|bound/|Sites|) is calculated from thePurified calf brain tubulin and chemicals were as described [32].
Epothilones A and B and the epothilone analogs were synthesized fluorescence anisotropy measurements as follows. Since the anisot-
ropy is an additive property, the anisotropy of a given mixture isas described [28, 31] and were employed as 10 mM stock solutions
in DMSO, which were stored at 20C. The solubility of these com- the sum of the anisotropy of its components. The anisotropies of
Flutax-2 in the two reference states (the nondisplaced ro and thepounds in water was greater than 50 M. The concentrations of
epothilone A and epothilone B were determined spectrophotometri- fully displaced rmin) are known, and the binding of the reference
ligand Flutax-2 in the absence of competitor (o) is calculated fromcally in ethanol employing the following extinction coefficients:
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the concentration of Flutax-2 binding sites and the binding constant tration of tubulin in the pellets versus total concentration) [45, 46].
Apparent polymer growth equilibrium constants were estimated asof Flutax-2, so the measured anisotropy values rx are transformed
into fractional saturation values x employing Equation 1: the reciprocal critical concentrations for polymerization (see Supple-
mental Data) [45, 46]. The assembled polymers were observed by
electron microscopy as described [38].vx 	
vo* (rx  r min)
(ro  r min)
. (1)
Supplemental Data
The fractional saturation values of Flutax-2 at different competitor Model mechanisms of ligand-induced assembly are discussed in
concentrations were best fitted to the equilibrium binding constant the supplemental data available at http://www.chembiol.com/cgi/
of the competitor assuming unitary stoichiometry and the binding content/full/11/2/225/DC1.
constant of the reference ligand (Flutax-2) with a PC program (J.F.D.,
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